More News

13 Jul 2020 Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV
09 Jul 2020 Zymeworks Announces New Multispecific Antibody Collaboration with Merck
09 Jul 2020 ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics
09 Jul 2020 Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target
07 Jul 2020 Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
07 Jul 2020 Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
06 Jul 2020 Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb to Develop Novel Therapeutic Candidates for Multiple Sclerosis and Neuro-inflammation Target
02 Jul 2020 Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction
01 Jul 2020 Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus
01 Jul 2020 Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular Vesicles Platform
30 Jun 2020 Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
29 Jun 2020 VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical
26 Jun 2020 Sosei Heptares and AbbVie Announce New Discovery Collaboration Targeting Inflammatory Diseases
24 Jun 2020 Yumanity Therapeutics Announces Strategic Research Collaboration and License Agreement with Merck Focused on Accelerating the Development of New Treatments for Neurodegenerative Diseases
24 Jun 2020 La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
22 Jun 2020 Minerva Biotechnologies Announces License Agreement with Memorial Sloan Kettering Cancer Center for 1XX Technology
18 Jun 2020 Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
18 Jun 2020 Rexahn and Ocuphire Enter into Definitive Merger Agreement
17 Jun 2020 Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb
16 Jun 2020 Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
16 Jun 2020 IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
15 Jun 2020 Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
13 Jun 2020 CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress
11 Jun 2020 Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies
11 Jun 2020 Novo Nordisk to acquire Corvidia Therapeutics and expand presence in cardiovascular disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up